Emory University
Gynecologic Oncology fellowship · Atlanta, GA · Program website
Obstetrics and Gynecology residency here · Other fellowships: Maternal-Fetal Medicine · Reproductive Endocrinology and Infertility
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Emory University's research in gynecologic oncology, which the program shares with other departments and affiliated hospitals.
Gynecologic Oncology at Emory Universityshared by every program there, not this program's own
Institution-level: all gynecologic oncology publications from Emory University and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Gynecologic Oncology research topics at Emory University
Papers in the window; each links to the list on OpenAlex.
Most cited at Emory University since 2024
All gynecologic oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline UpdateJulienne E. Bower et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 317
- Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast CancerNicholas C. Turner et al. · New England Journal of Medicine · 2024 · PubMed · cited 313
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018–2022Mackenzie Price et al. · Neuro-Oncology · 2025 · PubMed · cited 227
- Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01Aditya Bardia et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 224
- First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast CancerFrançois‐Clément Bidard et al. · New England Journal of Medicine · 2025 · PubMed · cited 212
- Unanswered questions following reports of secondary malignancies after CAR-T cell therapyBruce L. Levine et al. · Nature Medicine · 2024 · PubMed · cited 205
- Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen Joseph Bagley et al. · Nature Cancer · 2024 · PubMed · cited 200
- [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian M. Shuch et al. · The Lancet Oncology · 2024 · PubMed · cited 175
- PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast CancerErica L. Mayer et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 137
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/emory-university-gyn-onc"><img src="https://openprograms.org/programs/emory-university-gyn-onc/badge.svg" alt="Emory University Gynecologic Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.